Toll-like receptor 3-mediated tumor invasion in head and neck cancer

Oral Oncology

Volumn 48, Issue 3, 2012, Pages 226-232

  Chuang, Hui Ching ^a,b   Huang, Chao Cheng ^a,b   Chien, Chih Yen ^a   Chuang, Jiin Haur ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

CCL5; Head and neck cancer; IL 6; Oral cancer; Poly I:C; Toll like receptor 3

Indexed keywords

BAFILOMYCIN A1; I KAPPA B; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 6; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; RANTES; TOLL LIKE RECEPTOR 3;

ARTICLE; CANCER CELL; CANCER INVASION; CANCER TISSUE; CELL DIFFERENTIATION; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOKINE CCL5; HUMANS; I-KAPPA B PROTEINS; INTERFERON REGULATORY FACTOR-3; INTERLEUKIN-6; MICROARRAY ANALYSIS; MIDDLE AGED; MOUTH NEOPLASMS; PHOSPHORYLATION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 3;

EID: 84857446575     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.10.008     Document Type: Article

References (36)

1. B.B. Aggarwal, S. Shishodia, S.K. Sandur, M.K. Pandey, and G. Sethi Inflammation and cancer: how hot is the link? Biochem Pharmacol 72 2006 1605 1621 (Pubitemid 44666739)
2. C.Y. Chien, C.Y. Su, F.M. Fang, H.Y. Huang, H.C. Chuang, and C.M. Chen Lower prevalence but favorable survival for human papillomavirus - related squamous cell carcinoma of tonsil in Taiwan Oral Oncol 44 2008 174 179
3. Cancer Registry. Bureau of Health Promotion, Department of Health, Executive Yuan, Taiwan, Republic of China; 2008.
4. T. Kawai, and Akira TLR signaling Cell Death Differ 13 2006 816 825
5. B. Huang, J. Zhao, J.C. Unkeless, Z.H. Feng, and H. Xiong TLR signaling by tumor and immune cells: a double-edged sword Oncogene 27 2008 218 224
6. R.F. Wang, Y. Miyahara, and H.Y. Wang Toll-like receptors and immune regulation: implications for cancer therapy Oncogene 27 2008 181 189
7. B. Salaun, I. Coste, M.C. Rissoan, S.J. Lebecque, and T. Renno TLR3 can directly trigger apoptosis in human cancer cells J Immunol 176 2006 4894 4901
8. B. Salaun, S. Lebecque, S. Matikainen, D. Rimoldi, and P. Romero Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 13 2007 4565 4574 (Pubitemid 47219727)
9. C.F. Nicodemus, and J.S. Berek TLR3 agonists as immunotherapeutic agents Immunotherapy 2 2010 137 140
10. K. Fukuda, T. Watanabe, T. Tokisue, T. Tsujita, S. Nishikawa, and T. Hasegawa Modulation of doube-stranded RNA recognition by the N-terminal histidine-rich region of the human Toll-like receptor 3 J Biol Chem 283 2008 22787 22794
11. V.N. Pivtoraiko, A.J. Harrington, B.J. Mader, A.M. Luker, G.A. Caldwell, and K.A. Caldwell Low-dose Bafiomycin attenuates neuronal cell death associated with autophay-lysosome pathway dysfunction J Neurochem 114 2010 1193 1204
12. +-ATPase inhibitor induces apoptosis via lysosomal dysfunction in the human gastric cancer cell line MKN-1 J Biochem 134 2003 359 364 (Pubitemid 37288334)
13. A. Paone, D. Starace, R. Galli, F. Padula, P.D. Cesaris, and A. Filippini Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-α-dependent mechanism Carcinogenesis 29 2008 1334 1342
14. T. Ohta, H. Arakawa, F. Futagami, S. Fushida, H. Kitagawa, and M. Kayahara Bafilomycin A1 induces apoptosis in the human pancreatic cancer cell line CAPAN-1 J Pathol 185 1998 324 330 (Pubitemid 28320056)
15. D. Kademani, R.B. Bell, S. Bagberi, E. Hholmgren, E. Dierks, and B. Potter Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade J Oral Maxillofac Surg 63 2005 1599 1605 (Pubitemid 41525416)
16. S. Sklenicka, S. Gardiner, E.J. Dierks, B.E. Potter, and R.B. Bell Survivial analysis and risk factors for recurrence in oral squamous cell carcinoma: dose surgical salvage affect outcome? J Oral Maxillofac Surg 68 2010 1270 1275
17. C.T. Liao, K.H. Fan, H.M. Wang, H.M. Wang, S.H. Ng, and L.Y. Lee Identification of a high-risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 disease Int J Radiat Oncol Biol Phys 2010
18. E. Soudry, M. Preis, R. Hod, Y. Hamzany, T. Hadar, and G. Bahar Squamous cell carcinoma of the oral tongue in patients younger than 30 years: clinicopathologic features and outcome Clin Otolaryngol 35 2010 307 312
19. R. Pries, L. Hogrefe, L. Xie, H. Frenzel, C. Brocks, and C. Ditz Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer Int J Mol Med 21 2008 209 215 (Pubitemid 351222854)
20. S. González-Reyes, L. Marín, L. González, L.O. González, J.M. del Casar, and M.L. Lamelas Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis BMC Cancer 10 2010 665
21. B. Salau, L. Zitvogel, C. Asselin-Paturel, Y. Morel, K. Chemin, and C. Dubois TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer Cancer Res 71 2011 1607 1614
22. T. Morikawa, A. Sugiyama, H. Kume, S. Ota, T. Kashima, and K. Tomita Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma Clin Cancer Res 13 2007 5703 5709 (Pubitemid 47583894)
23. Q. Jiang, H. Wei, and Z. Tian Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway BMC Cancer 8 2008 12
24. D. Chiron, C. Pellat-Deceunynck, M. Amiot, R. Betaille, and G. Jego TLR3 ligand induces NF-kB activation and various fates of multiple myeloma cells depending on IFN-α production J Immunol 182 2009 4471 4478
25. A.J. Livengood, C.C.N. Wu, and D.A. Carson Opposing roles of RNA receptors TLR3 and RIG-I in the inflammatory response to double-strand RNA in a Kaposi's sarcoma cell line Cell Immunol 249 2007 55 62
26. K. Yoneda, K. Sugimoto, K. Shiraki, J. Tanaka, T. Beppu, and H. Fuke Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanism of TLR3-induced NF-κB activation and apoptosis Int J Oncol 33 2008 929 936
27. A. Paone, R. Galli, C. Gabellini, D. Lukashev, D. Starace, and A. Gorlach Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate carcinoma cell lines through hypoxia-inducible factor 1α Neoplasia 12 2010 539 549
28. L. Friboulet, C. Pioche-Durieu, S. Rodriguez, A. Valent, S. Souqure, and H. Ripoche Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to toll-like receptor 3-mediated apoptosis Neoplasia 11 2008 1183 1194
29. T. Ara, and Y.A. DeClerck Interleukin-6 in bone metastasis and cancer progression Eur J Cancer 46 2010 May 1223 1231
30. C.T. Allen, J.L. Ricker, Z. Chen, and C. Van Waes Role of activated nuclear factor-κB in the pathogenic and therapy of squamous cell carcinoma of the head and neck Head Neck 29 2007 959 971
31. F.G. Ondrey, G. Dong, J. Sunwoo, Z. Chen, J.S. Wolf, and C.V. Crowl-Bancroft Constitutive activation of transcript factor NFkB, AP-1, NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines Mol Carcino 26 1999 119 126
32. A. Mishra, A.C. Bharti, P. Varghese, D. Saluja, and B.C. Das Differential expression and activation of NFkB family proteins during oral carcinogenesis role of high risk human papillomavirus infection Int J Cancer 119 2006 2840 2850 (Pubitemid 44846236)
33. V. Sriuranpong, J.I. Park, P. Amornphimoltham, V. Patel, B.D. Nelkin, and J.S. Gutkind Epidermal Growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system Cancer Res 63 2003 2948 2956 (Pubitemid 36667168)
34. E.P. Adler, C.A. Lemken, N.S. Katchen, and R.A. Kurt A dual role for tumor-derived chemokine RANTES(CCL5) Immunol Lett 90 2003 187 194 (Pubitemid 37548476)
35. J.Y. Chuang, W.H. Yang, H.T. Chen, C.Y. Huang, T.W. Tan, and Y.T. Lin CCL5/CCR5 axis promotes the motility of human oral cancer cells J Cell Physiol 220 2009 418 426
36. C.Y. Huang, Y.C. Fong, C.Y. Lee, M.Y. Chen, and H.C. Tsai CCL5 increases lung cancer migration via PI3K, Akt and NF-kappa B pathway Biochem Pharmacol 77 2009 794 803